Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Alembic Pharmaceuticals Limited is a pharmaceutical company engaged in developing formulations and active pharmaceutical ingredients (API).
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Bloomberg Quint
1 month ago•Economic Times
1 month ago•Economic Times
1 month ago•Moneycontrol
1 month ago•The Hindu Businessline
1 month ago•Bloomberg Quint
1 month ago•Bloomberg Quint
1 month ago•Economic Times
1 month ago•Free Press Journal
1 month ago•Economic Times
Significant increase in volume has been observed in Alembic Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Alembic Pharmaceuticals Limited has submitted their response. | Download
Significant increase in volume has been observed in Alembic Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Alembic Pharmaceuticals Limited has submitted their response. | Download
Final • Div/Share: ₹ 8
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant